New hope for rare blood cancer: lenalidomide dose study completed
NCT ID NCT02302469
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study looked at the drug lenalidomide in 17 people with Waldenstrom macroglobulinemia, a rare blood cancer that had returned or stopped responding to other treatments. The main goal was to find a dose that is safe and tolerable. Researchers measured side effects and how many patients responded to the drug. The approach is about controlling the disease, not curing it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH LENS
Lens, 62307, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Centre Hospitalier de la côte basque
Bayonne, 64109, France
-
Ch Clermond Ferrand
Clermont-Ferrand, 63000, France
-
Ch Nantes
Nantes, 44 093, France
-
Chru Lille
Lille, 59037, France
-
Groupe hospitalier Pitié Salpétrière
Paris, 75651, France
Conditions
Explore the condition pages connected to this study.